Showing results (541-550 of 1,946) with videos related to

Sort By:
Pageof 195
RMD Open|May 31, 2020
Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?Sytske Anne Bergstra, Joy A Van Der Pol, Naghmeh Riyazi, et al.
RMD Open|May 22, 2020
Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysisJean W Liew, Irvin J Huang, Diana N Louden, et al.
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
RMD Open|May 7, 2020
One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatmentKristien Van der Elst, Patrick Verschueren, Diederik De Cock, et al.
RMD Open|May 7, 2020
Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkersNathalie Carrier, Artur J de Brum-Fernandes, Patrick Liang, et al.
RMD Open|May 7, 2020
Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis-a meta-analysisKentaro Kuzuya, Takayoshi Morita, Atsushi Kumanogoh
RMD Open|September 17, 2021
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA studyMitsumasa Kishimoto, Keisuke Ono, Sho Fukui, et al.
RMD Open|August 11, 2021
Use and detailed metric properties of patient-reported outcome measures for rheumatoid arthritis: a systematic review covering two decadesAyşe A Küçükdeveci, Atilla H Elhan, Beyza D Erdoğan, et al.
RMD Open|August 4, 2021
Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changesElisabeth Gjefsen, Kristina Gervin, Guro Goll, et al.
RMD Open|February 16, 2023
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progressionDinesh Khanna, Toby M Maher, Elizabeth R Volkmann, et al.
Pageof 195